|
1
|
National Research Council: Toxicological
Effects of Methylmercury. National Academy Press, Washington, DC,
pp221-232, 2000.
|
|
2
|
Okabe M and Takeuchi T: Distribution and
fate of mercury in tissue of human organs in Minamata disease.
Neurotoxicol. 74:1531–1537. 1980.
|
|
3
|
Yamamoto M, Yanagisawa R, Motomura E,
Nakamura M, Sakamoto M, Takeya M and Eto K: Increased methylmercury
toxicity related to obesity in diabetic KK-Ay mice. J Appl Toxicol.
34:914–923. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
4
|
Yamamoto M, Motomura E, Yanagisawa R,
Hoang VA, Mogi M, Mori T, Nakamura M, Takeya M and Eto K:
Evaluation of neurobehavioral impairment in methylmercury-treated
KK-Ay mice by dynamic weight-bearing test. J Appl Toxicol.
39:221–230. 2019.PubMed/NCBI View
Article : Google Scholar
|
|
5
|
Whitney NP, Eidem TM, Peng H, Huang Y and
Zheng JC: Inflammation mediates varying effects in neurogenesis:
Relevance to the pathogenesis of brain injury and neurodegenerative
disorders. J Neurochem. 108:1343–1359. 2009.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hu X, Leak RK, Shi Y, Suenaga J, Gao Y,
Zheng P and Chen J: Microglial and macrophage polarization - New
prospects for brain repair. Nat Rev Neurol. 11:56–64.
2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Muniroh M, Khan N, Koriyama C, Akiba S,
Vogel CF and Yamamoto M: Suppression of methylmercury-induced IL-6
and MCP-1 expressions by N-acetylcysteine in U-87MG human
astrocytoma cells. Life Sci. 134:16–21. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yamamoto M, Khan N, Muniroh M, Motomura E,
Yanagisawa R, Matsuyama T and Vogel CF: Activation of interleukin-6
and -8 expressions by methylmercury in human U937 macrophages
involves RelA and p50. J Appl Toxicol. 37:611–620. 2017.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
Hwang GW, Lee JY, Ryoke K, Matsuyama F,
Kim JM, Takahashi T and Naganuma A: Gene expression profiling using
DNA microarray analysis of the cerebellum of mice treated with
methylmercury. J Toxicol Sci. 36:389–391. 2011.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Godefroy D, Gosselin RD, Yasutake A,
Fujimura M, Combadière C, Maury-Brachet R, Laclau M, Rakwal R,
Melik-Parsadaniantz S, Bourdineaud JP, et al: The chemokine CCL2
protects against methylmercury neurotoxicity. Toxicol Sci.
125:209–218. 2012.PubMed/NCBI View Article : Google Scholar
|
|
11
|
David J, Nandakumar A, Muniroh M, Akiba S,
Yamamoto M and Koriyama C: Suppression of methylmercury-induced
MIP-2 expression by N-acetyl-L-cysteine in murine RAW264.7
macrophage cell line. Eur J Med Res. 22(45)2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Takeuchi T, Eto K and Tokunaga H: Mercury
level and histochemical distribution in a human brain with Minamata
disease following a long-term clinical course of twenty-six years.
Neurotoxicology. 10:651–657. 1989.PubMed/NCBI
|
|
13
|
Suda I, Totoki S, Uchida T and Takahashi
H: Degradation of methyl and ethyl mercury into inorganic mercury
by various phagocytic cells. Arch Toxicol. 66:40–44.
1992.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Suda I, Suda M and Hirayama K: Phagocytic
cells as a contributor to in vivo degradation of alkyl mercury.
Bull Environ Contam Toxicol. 51:394–400. 1993.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kim SH, Johnson VJ and Sharma RP: Mercury
inhibits nitric oxide production but activates proinflammatory
cytokine expression in murine macrophage: Differential modulation
of NF-kappaB and p38 MAPK signaling pathways. Nitric Oxide.
7:67–74. 2002.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Gardner RM, Nyland JF, Evans SL, Wang SB,
Doyle KM, Crainiceanu CM and Silbergeld EK: Mercury induces an
unopposed inflammatory response in human peripheral blood
mononuclear cells in vitro. Environ Health Perspect. 117:1932–1938.
2009.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wu Q, Li WK, Zhou ZP, Li YY, Xiong TW, Du
YZ, Wei LX and Liu J: The Tibetan medicine Zuotai differs from
HgCl2 and MeHg in producing liver injury in mice. Regul Toxicol
Pharmacol. 78:1–7. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Bavarsad Shahripour R, Harrigan MR and
Alexandrov AV: N-acetylcysteine (NAC) in neurological disorders:
Mechanisms of action and therapeutic opportunities. Brain Behav.
4:108–122. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
Samuni Y, Goldstein S, Dean OM and Berk M:
The chemistry and biological activities of N-acetylcysteine.
Biochim Biophys Acta. 1830:4117–4129. 2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Aremu DA, Madejczyk MS and Ballatori N:
N-acetylcysteine as a potential antidote and biomonitoring agent of
methylmercury exposure. Environ Health Perspect. 116:26–31.
2008.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Joshi D, Mittal DK, Shukla S, Srivastav AK
and Srivastav SK: N-acetyl cysteine and selenium protects mercuric
chloride-induced oxidative stress and antioxidant defense system in
liver and kidney of rats: A histopathological approach. J Trace
Elem Med Biol. 28:218–226. 2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Falluel-Morel A, Lin L, Sokolowski K,
McCandlish E, Buckley B and DiCicco-Bloom E: N-acetyl cysteine
treatment reduces mercury-induced neurotoxicity in the developing
rat hippocampus. J Neurosci Res. 90:743–750. 2012.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Yamamoto M, Hirano S, Vogel CF, Cui X and
Matsumura F: Selective activation of NF-kappaB and E2F by low
concentration of arsenite in U937 human monocytic leukemia cells. J
Biochem Mol Toxicol. 22:136–146. 2008.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yamamoto M, Takeya M, Ikeshima-Kataoka H,
Yasui M, Kawasaki Y, Shiraishi M, Majima E, Shiraishi S, Uezono Y,
Sasaki M, et al: Increased expression of aquaporin-4 with
methylmercury exposure in the brain of the common marmoset. J
Toxicol Sci. 37:749–763. 2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Livak K and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Tanimoto N, Terasawa M, Nakamura M, Kegai
D, Aoshima N, Kobayashi Y and Nagata K: Involvement of KC, MIP-2,
and MCP-1 in leukocyte infiltration following injection of necrotic
cells into the peritoneal cavity. Biochem Biophys Res Commun.
361:533–536. 2007.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Endlich B, Armstrong D, Brodsky J, Novotny
M and Hamilton TA: Distinct temporal patterns of
macrophage-inflammatory protein-2 and KC chemokine gene expression
in surgical injury. J Immunol. 168:3586–3594. 2002.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Rovai LE, Herschman HR and Smith JB: The
murine neutrophil-chemoattractant chemokines LIX, KC, and MIP-2
have distinct induction kinetics, tissue distributions, and
tissue-specific sensitivities to glucocorticoid regulation in
endotoxemia. J Leukoc Biol. 64:494–502. 1998.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Lee J, Cacalano G, Camerato T, Toy K,
Moore MW and Wood WI: Chemokine binding and activities mediated by
the mouse IL-8 receptor. J Immunol. 155:2158–2164. 1995.PubMed/NCBI
|
|
30
|
Zwijnenburg PJ, van der Poll T, Florquin
S, Roord JJ and Van Furth AM: IL-1 receptor type 1 gene-deficient
mice demonstrate an impaired host defense against pneumococcal
meningitis. J Immunol. 170:4724–4730. 2003.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Heine SJ, Olive D, Gao JL, Murphy PM,
Bukrinsky MI and Constant SL: Cyclophilin A cooperates with MIP-2
to augment neutrophil migration. J Inflamm Res. 4:93–104.
2011.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Armstrong DA, Major JA, Chudyk A and
Hamilton TA: Neutrophil chemoattractant genes KC and MIP-2 are
expressed in different cell populations at sites of surgical
injury. J Leukoc Biol. 75:641–648. 2004.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Hanisch UK and Kettenmann H: Microglia:
Active sensor and versatile effector cells in the normal and
pathologic brain. Nat Neurosci. 10:1387–1394. 2007.PubMed/NCBI View Article : Google Scholar
|
